Ono Pharmaceutical

-9.86%

More reviews (1)

Live  

Ono Pharmaceutical Co., Ltd. is a Japanese-based pharmaceutical company that was founded in 1717. The company develops, manufactures, and sells prescription medicines and over-the-counter products for a wide range of medical conditions. Ono Pharmaceutical is headquartered in Osaka, Japan and has operations in Asia, Europe, and the United States.
The company focuses on research and development in the fields of oncology, immunology, and neurology. Its products include treatments for cancer, immune disorders, infectious diseases, and other areas of unmet medical need.
Ono Pharmaceutical is committed to ethical business practices and responsible corporate citizenship. The company has implemented various initiatives to reduce its environmental impact and contribute to the well-being of communities it operates in.
Ono Pharmaceutical has collaborations and partnerships with other pharmaceutical companies, research institutions, and universities to enhance its research capabilities and bring innovative medicines to patients.
Overall, Ono Pharmaceutical is dedicated to improving the health and quality of life of individuals worldwide through the development of innovative and effective medications.

T25vIFBoYX JtYWNldXRp Y2FsIGlzIG EgY29tcGFu eSB0aGF0IG 1ha2VzIG1l ZGljaW5lcy B0byBoZWxw IHBlb3BsZS BmZWVsIGJl dHRlciB3aG VuIHRoZXkg YXJlIHNpY2 suIFRoaW5r IG9mIHRoZW 0gbGlrZSBz dXBlcmhlcm 8gc2NpZW50 aXN0cyB3aG 8gZGlzY292 ZXIgc3BlY2 lhbCBwb3Rp b25zIHRoYX QgY2FuIGN1 cmUgaWxsbm Vzc2VzLiBU aGV5IGZvY3 VzIG9uIHNl cmlvdXMgaG VhbHRoIHBy b2JsZW1zLC BsaWtlIGNh bmNlciwgd2 hlcmUgcGVv cGxlIHJlYW xseSBuZWVk IGVmZmVjdG l2ZSB0cmVh dG1lbnRzLj xicj5Pbm8g bWFrZXMgbW 9uZXkgYnkg Y3JlYXRpbm cgdGhlc2Ug bWVkaWNpbm VzIGFuZCB0 aGVuIHNlbG xpbmcgdGhl bSB0byBob3 NwaXRhbHMg YW5kIHBoYX JtYWNpZXMs IHdoaWNoIG lzIHdoZXJl IHBlb3BsZS BnbyB0byBn ZXQgdGhlaX IgbWVkaWNp bmUuIFdoZW 4gYSBkb2N0 b3IgdGhpbm tzIGEgcGF0 aWVudCBuZW VkcyBvbmUg b2YgT25v4o CZcyBtZWRp Y2luZXMsIH RoZXkgd2ls bCB3cml0ZS BhIHByZXNj cmlwdGlvbi 4gVGhlIHBo YXJtYWN5IH dpbGwgdGhl biBzZWxsIH RoYXQgbWVk aWNpbmUgdG 8gdGhlIHBh dGllbnQgb3 IgdGhlIGhv c3BpdGFsIH dpbGwgdXNl IGl0IHRvIG hlbHAgcGF0 aWVudHMgZG lyZWN0bHku IFRoaXMgaX MgaG93IE9u byBlYXJucy Btb25leSwg anVzdCBsaW tlIGEgc3Rv cmUgZWFybn MgbW9uZXkg Ynkgc2VsbG luZyB0b3lz IG9yIGNhbm R5Ljxicj5P bm8gaXMgc3 VjY2Vzc2Z1 bCBiZWNhdX NlIHRoZXkg aW52ZXN0IG EgbG90IG9m IHRpbWUgYW 5kIG1vbmV5 IGludG8gcm VzZWFyY2gg dG8gY3JlYX RlIG5ldyBh bmQgYmV0dG VyIG1lZGlj aW5lcy4gVG hleSBhbHNv IHdvcmsgd2 l0aCBvdGhl ciBzY2llbn Rpc3RzIGFu ZCBvcmdhbm l6YXRpb25z IHRvIGVuc3 VyZSB0aGVp ciBtZWRpY2 luZXMgYXJl IHNhZmUgYW 5kIGVmZmVj dGl2ZSBiZW ZvcmUgYW55 b25lIGNhbi B1c2UgdGhl bS4gQmVjYX VzZSB0aGV5 IGZvY3VzIG 9uIGltcG9y dGFudCBoZW FsdGggcHJv YmxlbXMgYW 5kIGFyZSBk ZWRpY2F0ZW QgdG8gaGVs cGluZyBwZW 9wbGUsIG1h bnkgZG9jdG 9ycyBhbmQg cGF0aWVudH MgdHJ1c3Qg T25vIGFuZC ByZWx5IG9u IHRoZWlyIG 1lZGljaW5l cy48YnI+SW 4gdGhlIGZ1 dHVyZSwgT2 5vIGlzIGxp a2VseSB0by Bjb250aW51 ZSBzdWNjZW VkaW5nIGZv ciBhIGZldy ByZWFzb25z LiBGaXJzdC wgcGVvcGxl IHdpbGwgYW x3YXlzIG5l ZWQgbmV3IG 1lZGljaW5l cywgYXMgaG VhbHRoIHBy b2JsZW1zIG NoYW5nZSBh bmQgbmV3IG 9uZXMgYXBw ZWFyLiBTZW NvbmQsIGlm IHRoZXkga2 VlcCBkb2lu ZyBnb29kIH Jlc2VhcmNo IGFuZCBmaW 5kaW5nIG5l dyB0cmVhdG 1lbnRzLCBk b2N0b3JzIH dpbGwgY29u dGludWUgdG 8gdXNlIHRo ZWlyIG1lZG ljaW5lcy4g TGFzdGx5LC BhZHZhbmNl bWVudHMgaW 4gdGVjaG5v bG9neSBhbm Qgc2NpZW5j ZSBtZWFuIH RoYXQgdGhl eSBjYW4gZm luZCBldmVu IGJldHRlci Bzb2x1dGlv bnMgdG8gaG VhbHRoIGlz c3Vlcywga2 VlcGluZyB0 aGVtIGF0IH RoZSBmb3Jl ZnJvbnQgb2 YgbWVkaWNp bmUgcHJvZH VjdGlvbi48 YnI+

MS4gRm9jdX NlZCBvbiBS ZXNlYXJjaC BhbmQgRGV2 ZWxvcG1lbn Q6IE9ubyBQ aGFybWFjZX V0aWNhbCBo YXMgYSBzdH JvbmcgZm9j dXMgb24gcm VzZWFyY2gg YW5kIGRldm Vsb3BtZW50 LCBpbnZlc3 RpbmcgYSBz aWduaWZpY2 FudCBwb3J0 aW9uIG9mIG l0cyByZXZl bnVlIGludG 8gdGhlIGRl dmVsb3BtZW 50IG9mIG5l dyBkcnVncy 4gVGhpcyBo YXMgYWxsb3 dlZCB0aGUg Y29tcGFueS B0byBpbnRy b2R1Y2UgaW 5ub3ZhdGl2 ZSBhbmQgZW ZmZWN0aXZl IHRyZWF0bW VudHMgZm9y IHZhcmlvdX MgZGlzZWFz ZXMuPGJyPj IuIFN0cm9u ZyBQaXBlbG luZSBvZiBE cnVnczogT2 5vIFBoYXJt YWNldXRpY2 FsIGhhcyBh IHJvYnVzdC BwaXBlbGlu ZSBvZiBkcn Vncywgd2l0 aCBzZXZlcm FsIHBvdGVu dGlhbCBibG 9ja2J1c3Rl ciBkcnVncy BpbiBkZXZl bG9wbWVudC 4gVGhpcyBl bnN1cmVzIG EgY29udGlu dW91cyBzb3 VyY2Ugb2Yg cmV2ZW51ZS Bncm93dGgg aW4gdGhlIG Z1dHVyZS48 YnI+My4gR2 xvYmFsIFBy ZXNlbmNlOi BUaGUgY29t cGFueSBoYX MgYSBnbG9i YWwgcHJlc2 VuY2UsIHdp dGggb3Blcm F0aW9ucyBp biBKYXBhbi wgdGhlIFVu aXRlZCBTdG F0ZXMsIGFu ZCBFdXJvcG UuIFRoaXMg YWxsb3dzIG l0IHRvIHRh cCBpbnRvIG RpZmZlcmVu dCBtYXJrZX RzIGFuZCBy ZWFjaCBhIH dpZGVyIHBh dGllbnQgcG 9wdWxhdGlv bi48YnI+NC 4gU3RyYXRl Z2ljIFBhcn RuZXJzaGlw czogT25vIG hhcyBmb3Jt ZWQgc3RyYX RlZ2ljIHBh cnRuZXJzaG lwcyB3aXRo IG90aGVyIH BoYXJtYWNl dXRpY2FsIG NvbXBhbmll cyBhbmQgYm lvdGVjaCBz dGFydHVwcy B0byBkZXZl bG9wIG5ldy BkcnVncyBh bmQgdGVjaG 5vbG9naWVz LiBUaGlzIG NvbGxhYm9y YXRpb24gaG VscHMgdGhl IGNvbXBhbn kgYWNjZXNz IGN1dHRpbm ctZWRnZSBy ZXNlYXJjaC BhbmQgZXhw YW5kIGl0cy Bwcm9kdWN0 IHBvcnRmb2 xpby48YnI+ NS4gQ29tbW l0bWVudCB0 byBJbm5vdm F0aW9uOiBP bm8gUGhhcm 1hY2V1dGlj YWwgaGFzIG Egc3Ryb25n IGNvbW1pdG 1lbnQgdG8g aW5ub3ZhdG lvbiBhbmQg aXMgY29uc3 RhbnRseSBp bnZlc3Rpbm cgaW4gbmV3 IHRlY2hub2 xvZ2llcyBh bmQgYXBwcm 9hY2hlcyB0 byBib29zdC BkcnVnIGRl dmVsb3BtZW 50IGFuZCBp bXByb3ZlIH BhdGllbnQg b3V0Y29tZX MuPGJyPjYu IEZvY3VzIG 9uIFJhcmUg RGlzZWFzZX M6IFRoZSBj b21wYW55IG hhcyBhIHN0 cm9uZyBmb2 N1cyBvbiBy YXJlIGRpc2 Vhc2VzLCB3 aGVyZSB0aG VyZSBpcyBh IHNpZ25pZm ljYW50IHVu bWV0IG1lZG ljYWwgbmVl ZC4gVGhpcy Bjb21taXRt ZW50IGhhcy BsZWQgdG8g dGhlIHN1Y2 Nlc3NmdWwg ZGV2ZWxvcG 1lbnQgb2Yg c2V2ZXJhbC BkcnVncyBm b3IgcmFyZS BkaXNlYXNl cy48YnI+Ny 4gU29jaWFs IFJlc3Bvbn NpYmlsaXR5 OiBPbm8gUG hhcm1hY2V1 dGljYWwgaG FzIGEgc3Ry b25nIGVtcG hhc2lzIG9u IHNvY2lhbC ByZXNwb25z aWJpbGl0eS BhbmQgaXMg Y29tbWl0dG VkIHRvIHBy b3ZpZGluZy BhZmZvcmRh YmxlIGFuZC BhY2Nlc3Np YmxlIG1lZG ljaW5lcyB0 byBwYXRpZW 50cyBpbiBu ZWVkLjxicj 44LiBTdHJv bmcgRmluYW 5jaWFsIFBl cmZvcm1hbm NlOiBUaGUg Y29tcGFueS BoYXMgY29u c2lzdGVudG x5IGFjaGll dmVkIHN0cm 9uZyBmaW5h bmNpYWwgcG VyZm9ybWFu Y2UsIHdpdG ggc3RlYWR5 IHJldmVudW UgYW5kIHBy b2ZpdCBncm 93dGguIFRo aXMgc3RhYm lsaXR5IGFu ZCBmaW5hbm NpYWwgc3Ry ZW5ndGggZ2 l2ZSB0aGVt IHRoZSByZX NvdXJjZXMg dG8gaW52ZX N0IGluIG5l dyBkcnVnIG RldmVsb3Bt ZW50Ljxicj 45LiBFbXBs b3llZS1Gcm llbmRseSBQ b2xpY2llcz ogT25vIGhh cyBiZWVuIH JlY29nbml6 ZWQgYXMgb2 5lIG9mIHRo ZSBiZXN0IG NvbXBhbmll cyB0byB3b3 JrIGZvciBp biBKYXBhbi 4gSXQgaGFz IGEgcG9zaX RpdmUgd29y ayBjdWx0dX JlIGFuZCBl bXBsb3llZS 1mcmllbmRs eSBwb2xpY2 llcywgd2hp Y2ggaGF2ZS BoZWxwZWQg YXR0cmFjdC BhbmQgcmV0 YWluIHRvcC B0YWxlbnQu PGJyPjEwLi BDb21taXRt ZW50IHRvIF N1c3RhaW5h YmlsaXR5Oi BPbm8gaXMg Y29tbWl0dG VkIHRvIHN1 c3RhaW5hYm xlIGRldmVs b3BtZW50IG FuZCBoYXMg c2V0IHRhcm dldHMgZm9y IHJlZHVjaW 5nIGl0cyBl bnZpcm9ubW VudGFsIGlt cGFjdC4gVG hlIGNvbXBh bnkgYWxzby BzdXBwb3J0 cyB2YXJpb3 VzIHNvY2lh bCBpbml0aW F0aXZlcyBh bmQgaXMgd2 9ya2luZyB0 b3dhcmRzIG J1aWxkaW5n IGEgbW9yZS BzdXN0YWlu YWJsZSBmdX R1cmUu

VGhlIE9uby BQaGFybWFj ZXV0aWNhbC BDb21wYW55 IGlzIGEgcG hhcm1hY2V1 dGljYWwgY2 9tcGFueSB0 aGF0IGZvY3 VzZXMgb24g dGhlIHJlc2 VhcmNoLCBk ZXZlbG9wbW VudCwgcHJv ZHVjdGlvbi wgYW5kIHNh bGUgb2YgcG hhcm1hY2V1 dGljYWwgcH JvZHVjdHMu IFRoZWlyIG J1c2luZXNz IG1vZGVsIG lzIGJhc2Vk IG9uIHByb3 ZpZGluZyBp bm5vdmF0aX ZlIGFuZCBl ZmZlY3Rpdm UgbWVkaWNh bCBzb2x1dG lvbnMgZm9y IHZhcmlvdX MgZGlzZWFz ZXMgYW5kIG 1lZGljYWwg Y29uZGl0aW 9ucy48YnI+ VGhleSBjb2 xsYWJvcmF0 ZSB3aXRoIH Jlc2VhcmNo IGluc3RpdH V0ZXMsIHVu aXZlcnNpdG llcywgYW5k IG90aGVyIH BoYXJtYWNl dXRpY2FsIG NvbXBhbmll cyB0byBkZX ZlbG9wIG5l dyBkcnVncy BhbmQgdHJl YXRtZW50cy 4gT25vIFBo YXJtYWNldX RpY2FsIGFs c28gaGFzIG Egc3Ryb25n IGZvY3VzIG 9uIGludmVz dGluZyBpbi BjdXR0aW5n LWVkZ2UgdG VjaG5vbG9n aWVzIGFuZC Bjb250aW51 b3VzbHkgaW 1wcm92aW5n IHRoZWlyIG V4aXN0aW5n IHByb2R1Y3 RzLjxicj5U aGUgY29tcG FueSdzIG1h aW4gc291cm NlIG9mIHJl dmVudWUgY2 9tZXMgZnJv bSB0aGUgc2 FsZXMgb2Yg dGhlaXIgcG hhcm1hY2V1 dGljYWwgcH JvZHVjdHMs IGJvdGggaW 4gSmFwYW4g YW5kIGludG VybmF0aW9u YWxseS4gVG hleSBoYXZl IGEgZGl2ZX JzZSBwb3J0 Zm9saW8gb2 YgcHJvZHVj dHMgdGhhdC Bjb3ZlciB2 YXJpb3VzIH RoZXJhcGV1 dGljIGFyZW FzLCBzdWNo IGFzIG9uY2 9sb2d5LCBp bW11bm9sb2 d5LCBuZXVy b2xvZ2ljYW wgZGlzb3Jk ZXJzLCBhbm QgaW5mZWN0 aW91cyBkaX NlYXNlcy48 YnI+T25vIF BoYXJtYWNl dXRpY2FsIG Fsc28gdXNl cyBhIGxpY2 Vuc2luZyBi dXNpbmVzcy Btb2RlbCB0 byBleHBhbm QgdGhlaXIg cHJvZHVjdC Bwb3J0Zm9s aW8gYnkgcG FydG5lcmlu ZyB3aXRoIG 90aGVyIGNv bXBhbmllcy B0byBkZXZl bG9wIGFuZC Bjb21tZXJj aWFsaXplIH RoZWlyIHBy b2R1Y3RzIG luIGRpZmZl cmVudCBtYX JrZXRzLiBU aGV5IGFsc2 8gb2ZmZXIg Y29udHJhY3 QgbWFudWZh Y3R1cmluZy BzZXJ2aWNl cyB0byBvdG hlciBwaGFy bWFjZXV0aW NhbCBjb21w YW5pZXMsIG dlbmVyYXRp bmcgYWRkaX Rpb25hbCBy ZXZlbnVlLj xicj5JbiBh ZGRpdGlvbi B0byB0aGVp ciBjb21tZX JjaWFsIGFj dGl2aXRpZX MsIE9ubyBQ aGFybWFjZX V0aWNhbCBh bHNvIGludm VzdHMgaW4g Y29ycG9yYX RlIHNvY2lh bCByZXNwb2 5zaWJpbGl0 eSBpbml0aW F0aXZlcyB0 byBjb250cm lidXRlIHRv IHRoZSB3ZW xsLWJlaW5n IG9mIHNvY2 lldHkuIFRo aXMgaW5jbH VkZXMgc3Vw cG9ydGluZy BoZWFsdGhj YXJlLXJlbG F0ZWQgcHJv amVjdHMgYW 5kIGluaXRp YXRpdmVzIG luIGRldmVs b3BpbmcgY2 91bnRyaWVz Ljxicj5Pdm VyYWxsLCB0 aGUgY29tcG FueSdzIGJ1 c2luZXNzIG 1vZGVsIGZv Y3VzZXMgb2 4gY29udGlu dW91cyBpbm 5vdmF0aW9u LCBzdHJhdG VnaWMgY29s bGFib3JhdG lvbnMsIGFu ZCBldGhpY2 FsIGJ1c2lu ZXNzIHByYW N0aWNlcyB0 byBwcm92aW RlIGhpZ2gt cXVhbGl0eS BhbmQgZWZm ZWN0aXZlIG 1lZGljYWwg c29sdXRpb2 5zIGZvciBw YXRpZW50cy B3b3JsZHdp ZGUu

AI can indeed pose material threats to pharmaceutical companies like Ono Pharmaceutical in several ways, although the impact may vary based on the company’s specific circumstances and strategies.
1. Substitution: AI-driven technologies can lead to the development of new treatments or therapies that may serve as substitutes for existing products. For instance, advancements in areas such as personalized medicine, gene therapy, or even AI-designed small molecules could render existing drugs less effective or obsolete if they offer superior outcomes.
2. Disintermediation: The rise of digital health platforms and AI-driven drug discovery systems might bypass traditional pharmaceutical companies. Patients could access treatments directly through AI applications or even participate in decentralized clinical trials that allow for drug development without the need for conventional pharmaceutical intermediaries. This could diminish the role of companies like Ono and disrupt their revenue streams.
3. Margin Pressure: AI can enhance operational efficiencies in drug discovery, clinical trials, and manufacturing processes, lowering costs and increasing competition. If competitors effectively leverage AI to reduce their expenses significantly, they may offer similar products at lower prices, putting pressure on Ono’s profit margins. Additionally, AI-driven analytics can lead to more targeted marketing, potentially increasing competition for customer loyalty.
4. Regulatory Challenges: As AI technologies evolve, regulatory bodies may impose new guidelines influencing how drugs are developed and marketed. If Ono does not adapt quickly to these changes or invest in AI capabilities, it risks falling behind its competitors who can navigate the regulatory landscape more effectively.
5. Data Utilization and Intellectual Property: Companies that effectively utilize AI to analyze large datasets for drug development or patient outcomes can gain significant competitive advantages. Ono may face challenges in maintaining its intellectual property and competitive edge if rivals leverage AI to create similar or better products faster.
In summary, while AI presents opportunities for innovation and improvement within the pharmaceutical landscape, it also poses significant threats related to substitution, disintermediation, and margin pressures. Companies like Ono Pharmaceutical will need to strategically adopt AI technologies and adapt their business models to navigate these challenges successfully.

The sensitivity of Ono Pharmaceutical’s earnings, cash flow, and valuation to changes in interest rates can be influenced by several factors:
1. Earnings Sensitivity: Changes in interest rates can affect Ono’s cost of borrowing. If interest rates rise, the cost of debt increases, potentially impacting earnings through higher interest expenses. Conversely, if rates fall, borrowing costs could decrease, positively impacting earnings. Additionally, interest rates affect overall economic conditions, which can impact demand for pharmaceuticals.
2. Cash Flow Sensitivity: Cash flow is closely related to earnings, but it can also be influenced by interest rate changes in terms of financing activities. Higher interest rates could lead to reduced cash flows if the company has significant debt servicing obligations. Cash flows from operating activities may also be affected due to changes in economic conditions driven by interest rate fluctuations.
3. Valuation Sensitivity: Valuation for companies like Ono is often assessed using discounted cash flow (DCF) analysis, where future cash flows are discounted back to their present value using a discount rate that is influenced by prevailing interest rates. Higher interest rates generally lead to a higher discount rate, which would lower the present value of future cash flows and thus decrease the overall valuation of the company. In contrast, lower interest rates typically result in a lower discount rate, potentially increasing the company’s valuation.
Overall, like many companies, Ono Pharmaceutical is likely to experience some sensitivity to interest rate changes, particularly through their financing costs and the valuation implications arising from discounted future cash flows. The exact sensitivity can vary depending on Ono’s specific financial structure and market conditions at any given time.

QSByZWFsaX N0aWMgc2Nl bmFyaW8gdG hhdCBjb3Vs ZCBwZXJtYW 5lbnRseSBp bXBhaXIgT2 5vIFBoYXJt YWNldXRpY2 Fs4oCZcyBl Y29ub21pY3 Mgb3ZlciB0 aGUgbmV4dC Az4oCTNSB5 ZWFycyBpcy B0aGUgZmFp bHVyZSBvZi BrZXkgZHJ1 ZyBjYW5kaW RhdGVzIGlu IHRoZWlyIH BpcGVsaW5l LCBwYXJ0aW N1bGFybHkg aW4gYSBjcm l0aWNhbCB0 aGVyYXBldX RpYyBhcmVh IHdoZXJlIH RoZXkgaGF2 ZSBpbnZlc3 RlZCBzaWdu aWZpY2FudC ByZXNvdXJj ZXMuIElmIG 1ham9yIGNs aW5pY2FsIH RyaWFscyBm b3IgdGhlaX IgcHJvbWlz aW5nIGRydW dzIHdlcmUg dG8gZmFpbC BkdWUgdG8g bGFjayBvZi BlZmZpY2Fj eSBvciBzYW ZldHkgaXNz dWVzLCBpdC Bjb3VsZCBz dWJzdGFudG lhbGx5IGlt cGFjdCB0aG VpciByZXZl bnVlIHByb2 plY3Rpb25z IGFuZCBtYX JrZXQgcG9z aXRpb24uPG JyPkluIHRo aXMgc2Nlbm FyaW8sIHNl dmVyYWwgaW 1tZWRpYXRl IHJlcGVyY3 Vzc2lvbnMg Y291bGQgYm Ugb2JzZXJ2 ZWQ6PGJyPj EuIDxzdHJv bmc+UmVkdW NlZCBSZXZl bnVlPC9zdH Jvbmc+OiBU aGUgZmFpbH VyZSBvZiBr ZXkgZHJ1Zy BjYW5kaWRh dGVzIHdvdW xkIGxpa2Vs eSBsZWFkIH RvIGEgc2hh cnAgZGVjbG luZSBpbiBw cm9qZWN0ZW QgZnV0dXJl IHJldmVudW VzLiBPbm8g cmVsaWVzIG hlYXZpbHkg b24gaXRzIH BoYXJtYWNl dXRpY2FsIH Byb2R1Y3Rz IGZvciByZX ZlbnVlIGdl bmVyYXRpb2 4sIGFuZCBs b3NpbmcgZm xhZ3NoaXAg ZHJ1Z3MgY2 91bGQgcmVz dWx0IGluIG Egc2lnbmlm aWNhbnQgcm V2ZW51ZSBk cm9wLCBwb3 NzaWJseSBi eSAzMC01MC UuPGJyPjIu IDxzdHJvbm c+TWFyZ2lu cyBQcmVzc3 VyZTwvc3Ry b25nPjogQX MgcmV2ZW51 ZXMgZGVjbG luZSwgcHJv Zml0IG1hcm dpbnMgd291 bGQgYWxzby B0YWtlIGEg aGl0LiBGaX hlZCBjb3N0 cyByZWxhdG VkIHRvIFIm YW1wO0QgYW 5kIG9wZXJh dGlvbnMgd2 91bGQgcmVt YWluLCBidX Qgd2l0aCBy ZWR1Y2VkIH NhbGVzLCB0 aGUgY29tcG FueSBtaWdo dCBmYWNlIH ByZXNzdXJl IHRvIGN1dC BwcmljZXMg b3IgaW5jcm Vhc2UgZGlz Y291bnRzIH RvIG1vdmUg ZXhpc3Rpbm cgcHJvZHVj dHMsIGZ1cn RoZXIgY29t cHJlc3Npbm cgbWFyZ2lu cy4gT3Blcm F0aW5nIG1h cmdpbnMgY2 91bGQgZGVj bGluZSBieS BzZXZlcmFs IHBlcmNlbn RhZ2UgcG9p bnRzLCBtb3 ZpbmcgZnJv bSBoZWFsdG h5IHBvc2l0 aXZlIHRlcn JpdG9yeSB0 byBwb3Rlbn RpYWxseSBu ZWdhdGl2ZS BwZXJjZW50 YWdlcy48Yn I+My4gPHN0 cm9uZz5DYX NoIEZsb3cg SXNzdWVzPC 9zdHJvbmc+ OiBDYXNoIG Zsb3cgd291 bGQgYmUgYW ZmZWN0ZWQg YXMgd2VsbC 4gV2l0aCBs b3dlciByZX ZlbnVlcywg dGhlIGNvbX BhbnkgbWln aHQgc3RydW dnbGUgdG8g bWFpbnRhaW 4gcG9zaXRp dmUgb3Blcm F0aW9uYWwg Y2FzaCBmbG 93LiBUaGlz IHNpdHVhdG lvbiBjb3Vs ZCBwcm9tcH QgdGhlIGNv bXBhbnkgdG 8gbG9vayBm b3IgZXh0ZX JuYWwgZmlu YW5jaW5nLC BsZWFkaW5n IHRvIGluY3 JlYXNlZCBk ZWJ0IGxldm VscyBhbmQg aGlnaGVyIG ludGVyZXN0 IGV4cGVuc2 VzLiBOZWdh dGl2ZSBjYX NoIGZsb3cg Y291bGQgcG Vyc2lzdCBm b3Igc2V2ZX JhbCBxdWFy dGVycywgcm VxdWlyaW5n IHNldmVyZS Bjb3N0LWN1 dHRpbmcgbW Vhc3VyZXMg b3IgYSByZW V2YWx1YXRp b24gb2YgaW 52ZXN0bWVu dCBzdHJhdG VnaWVzLjxi cj40LiA8c3 Ryb25nPkJh bGFuY2UgU2 hlZXQgSW1w YWN0PC9zdH Jvbmc+OiBU aGUgb3Zlcm FsbCBiYWxh bmNlIHNoZW V0IGhlYWx0 aCBjb3VsZC BkZXRlcmlv cmF0ZSBkdW UgdG8gYSBj b21iaW5hdG lvbiBvZiBm YWxsaW5nIG Nhc2ggcmVz ZXJ2ZXMgYW 5kIGluY3Jl YXNlZCBsaW FiaWxpdGll cyBmcm9tIG JvcnJvd2lu Zy4gVGhlIH JhdGlvIG9m IGRlYnQgdG 8gZXF1aXR5 IGNvdWxkIH Jpc2Ugc2ln bmlmaWNhbn RseSwgbGVh ZGluZyB0by Bjb25jZXJu cyBhYm91dC Bzb2x2ZW5j eS4gSWYgdG hlIGNvbXBh bnkgbmVlZH MgdG8gcmFp c2UgZnVuZH MgdGhyb3Vn aCBlcXVpdH kgaXNzdWFu Y2UsIHRoaX MgY291bGQg ZGlsdXRlIG V4aXN0aW5n IHNoYXJlaG 9sZGVyIHZh bHVlLjxicj 5JbiBzdW1t YXJ5LCBpZi BrZXkgZHJ1 Z3Mgd2VyZS B0byBmYWls IGluIGNsaW 5pY2FsIHRy aWFscywgT2 5vIFBoYXJt YWNldXRpY2 Fs4oCZcyBy ZXZlbnVlIG NvdWxkIGRy b3AgZHJhbW F0aWNhbGx5 LCBtYXJnaW 5zIHdvdWxk IHRpZ2h0ZW 4sIGFuZCBj YXNoIGZsb3 cgbWF5IGJl Y29tZSBuZW dhdGl2ZSwg cHJlc3N1cm luZyB0aGVp ciBiYWxhbm NlIHNoZWV0 IGFuZCBsZW FkaW5nIHRv IGhpZ2hlci BkZWJ0IGxl dmVscy4gT3 ZlcmFsbCwg dGhpcyBzY2 VuYXJpbyBj b3VsZCBsZW FkIHRvIGxv bmctdGVybS BkYW1hZ2Ug dG8gdGhlIG NvbXBhbnni gJlzIGZpbm FuY2lhbCBz dGFiaWxpdH kgYW5kIG1h cmtldCByZX B1dGF0aW9u LCBtYWtpbm cgcmVjb3Zl cnkgY2hhbG xlbmdpbmcu PGJyPg==

CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3MvVE wySENGR0E3 dkdnVGtPa2 o0UGwud2Vi cCIgYWx0PS JPbm8gUGhh cm1hY2V1dG ljYWwiIHRp dGxlPSJPbm 8gUGhhcm1h Y2V1dGljYW wiICBjbGFz cz0iaW1nLW ZsdWlkIiBo ZWlnaHQ9NT Agd2lkdGg9 NTAgbG9hZG luZz0nbGF6 eScgc3R5bG U9J2JvcmRl ci1yYWRpdX M6IDZweDsn PgoKICAgIC AgICAgICAg ICAgICAgIC A8ZGl2IHN0 eWxlPSdmbG V4OiAxOyB0 ZXh0LWFsaW duOiBjZW50 ZXI7IG1hcm dpbi1sZWZ0 OiA1cHg7Jz 4KICAgICAg ICAgICAgIC AgICAgICAg ICAgPHAgc3 R5bGU9J2Zv bnQtc2l6ZT ogMjZweDsg Y29sb3I6IC MzMzM7IG1h cmdpbi1ib3 R0b206IDE1 cHg7Jz4KIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIPCfk4 ggV2FudCB0 byByZWFkIG 1vcmUgYWJv dXQgT25vIF BoYXJtYWNl dXRpY2FsPw ogICAgICAg ICAgICAgIC AgICAgICAg ICA8L3A+Cg ogICAgICAg ICAgICAgIC AgICAgICAg ICA8YSBocm VmPSdpbmRl eC5waHA/cG FnZT1zaWdu dXAnIHN0eW xlPScKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICMw MDdCRkY7Ci AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBjb2 xvcjogI2Zm ZjsKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IHBhZGRpbm c6IDEwcHgg MjBweDsKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIGJvcm Rlci1yYWRp dXM6IDVweD sKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIH RleHQtZGVj b3JhdGlvbj ogbm9uZTsK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIGZv bnQtd2VpZ2 h0OiBib2xk OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luLX JpZ2h0OiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgdHJhbn NpdGlvbjog YmFja2dyb3 VuZC1jb2xv ciAwLjNzIG Vhc2U7Jwog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgb25t b3VzZW92ZX I9J3RoaXMu c3R5bGUuYm Fja2dyb3Vu ZENvbG9yPS IjMDA1NmIz IicKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IG9ubW91c2 VvdXQ9J3Ro aXMuc3R5bG UuYmFja2dy b3VuZENvbG 9yPSIjMDA3 QkZGIic+Ci AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBTaW duIHVwIGZv ciBmcmVlCi AgICAgICAg ICAgICAgIC AgICAgICAg IDwvYT4KCi AgICAgICAg ICAgICAgIC AgICAgICAg IDxzcGFuIH N0eWxlPSdt YXJnaW46ID AgOHB4OyBj b2xvcjogIz U1NTsnPm9y PC9zcGFuPg oKICAgICAg ICAgICAgIC AgICAgICAg ICAgPGEgaH JlZj0naW5k ZXgucGhwP3 BhZ2U9bG9n aW4nIHN0eW xlPScKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIGNvbG9y OiAjMDA3Qk ZGOwogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgdGV4dC1k ZWNvcmF0aW 9uOiB1bmRl cmxpbmU7Ci AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBmb2 50LXdlaWdo dDogNTAwOy c+CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Bsb2cgaW4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgPC9hPgoK CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDxwIHN0 eWxlPSdtYX JnaW4tdG9w OiAxNXB4Oy Bmb250LXNp emU6IDEzcH g7IGZvbnQt d2VpZ2h0Oi Bib2xkOyBj b2xvcjogI2 QzMmYyZjsn PgogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg 8J+TmiBZb3 VyIGZyZWUg Y29weSBvZi A8aT4iVGhl IENoZWNrbG lzdCBWYWx1 ZSBJbnZlc3 RvciDigJQg QSBTbWFydG VyIFdheSB0 byBQaWNrIF N0b2NrcyI8 L2k+IGlzIH dhaXRpbmcK ICAgICAgIC AgICAgICAg ICAgICAgIC AgPC9wPgoK ICAgICAgIC AgICAgICAg ICAgICAgIC AgPCEtLQog ICAgICAgIC AgICAgICAg ICAgICAgIC A8ZGl2IHN0 eWxlPSdtYX JnaW4tdG9w OiAxMnB4Oy Bmb250LXNp emU6IDEzcH g7IGNvbG9y OiAjNDQ0Oy c+CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC BTaWduIHVw IG5vdyBhbm QgZ2V0IG91 ciBmcmVlIG VCb29rIAog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgPGI+ VGhlIENoZW NrbGlzdCBW YWx1ZSBJbn Zlc3RvciDi gJQgQSBTbW FydGVyIFdh eSB0byBQaW NrIFN0b2Nr czwvYj4KIC AgICAgICAg ICAgICAgIC AgICAgICAg PC9kaXY+Ci AgICAgICAg ICAgICAgIC AgICAgICAg IC0tPgogIC AgICAgICAg ICAgICAgIC AgICAgICA8 IS0tCiAgIC AgICAgICAg ICAgICAgIC AgICAgIDxk aXYgc3R5bG U9J21hcmdp bi10b3A6ID E2cHg7IGZv bnQtc2l6ZT ogMTRweDsg Y29sb3I6IC M0NDQ7IGZv bnQtZmFtaW x5OiAtYXBw bGUtc3lzdG VtLCBCbGlu a01hY1N5c3 RlbUZvbnQs IFNlZ29lIF VJLCBSb2Jv dG8sIEhlbH ZldGljYSBO ZXVlLCBzYW 5zLXNlcmlm OyBsaW5lLW hlaWdodDog MS42Oyc+Ci AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBIYX ZlIHlvdSBo ZWFyZCBhYm 91dCBvdXIg c2hvcnQgPH N0cm9uZyBz dHlsZT0nZm 9udC13ZWln aHQ6IDYwMD snPkRhaWx5 IFZpZGVvIE 5ld3NsZXR0 ZXI8L3N0cm 9uZz4/CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICA8YSBo cmVmPSdodH RwczovL3d3 dy5pbnNpZ2 h0ZnVsdmFs dWUuY29tL2 5ld3NsZXR0 ZXIucGhwJy B0YXJnZXQ9 J19ibGFuay cgc3R5bGU9 J2NvbG9yOi AjMDA3QkZG OyB0ZXh0LW RlY29yYXRp b246IG5vbm U7IGZvbnQt d2VpZ2h0Oi A1MDA7IG1h cmdpbi1sZW Z0OiA2cHg7 Jz4KICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBGaW 5kIG91dCBt b3JlCiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICA8L2E+Ci AgICAgICAg ICAgICAgIC AgICAgICAg IDwvZGl2Pg ogICAgICAg ICAgICAgIC AgICAgICAg ICAtLT4KIC AgICAgICAg ICAgICAgIC AgICA8L2Rp dj4KICAgIC AgICAgICAg ICAgIDwvZG l2PgogICAg ICAgICAgIC A8L2Rpdj4K ICAgICAgIC AgICAgCiAg ICAgICAgCi AgICAgICAg PHNwYW4gY2 xhc3M9J2Js dXJyZWQtdG V4dCc+CiAg ICAgICAgIC AgIGJXRnJa WE1nZEcgRm liR1YwY3p4 aSBjajR4TG lCR2IzIFZ1 WkdWa0lHbH UgSURFM01U YzZJRiBSb1 pTQlBibThn IFVHaGhjbT FoWTIgVjFk R2xqWVd3Zy BZMjl0Y0dG dWVTIEIzWV hNZ1ptOTEg Ym1SbFpDQn BiaSBBeE56 RTNJR0Z6IE lHRWdkSEpo WkcgbDBhVz l1WVd3ZyBh R1Z5WW1Gc0 lHIDFsWkds amFXNWwgSU hOMGIzSmxJ RyBsdUlFOX pZV3RoIExD QktZWEJoYm kgNGdTWFFn ZDJGeiBJR0 5oYkd4bFpD IEJQYm04Z1 IyVnUgZW1G bGJXOXVJRi BOb2IzUmxi aTQ4IFluSS tNaTRnUlcg NTBaWEpsWk NCMCBhR1Vn Y0doaGNtID FoWTJWMWRH bGogWVd3Z2 FXNWtkWCBO MGNua2dhVz RnIE1UZzVP VG9nU1cgNG dNVGc1T1N3 ZyBkR2hsSU dOdmJYIEJo Ym5rZ2MzUm ggY25SbFpD QnBiWCBCdm NuUnBibWNn IGNHaGhjbT FoWTIgVjFk R2xqWVd3Zy BjbUYzSUcx aGRHIFZ5YV dGc2N5Qm0g Y205dElHRm ljbSA5aFpD QmhibVFnIF pXNTBaWEps WkMgQjBhR1 VnY0doaCBj bTFoWTJWMW RHIGxqWVd3 Z2FXNWsgZF hOMGNua3VQ RyBKeVBqTX VJRVpwIGNu TjBJRXBoY0 cgRnVaWE5s SUdOdiBiWE JoYm5rZ2RH IDhnYldGdW RXWmggWTNS MWNtVWdjRy BWdWFXTnBi R3hwIGJqb2 dTVzRnTVQg azBOaXdnVD I1diBJRkJv WVhKdFlXIE 5sZFhScFky RnMgSUdKbF kyRnRaUyBC MGFHVWdabW x5IGMzUWdT bUZ3WVcgNW xjMlVnWTI5 dCBjR0Z1ZV NCMGJ5IEJ0 WVc1MVptRm ogZEhWeVpT QndaVyA1cF kybHNiR2x1 IExqeGljaj QwTGkgQkVa WFpsYkc5dy BaV1FnU21G d1lXIDdpZ0 pseklHWnAg Y25OMElIUn lZVyA1eGRX bHNhWHBsIG Nqb2dTVzRn TVQgazFOU3 dnZEdobCBJ R052YlhCaG JuIGtnWkdW MlpXeHYgY0 dWa0lFcGhj RyBGdTRvQ1 pjeUJtIGFY SnpkQ0IwY2 0gRnVjWFZw YkdsNiBaWE lnWTJGc2JH IFZrSUVWc1 pXNXAgZFcw Z1JXeHBlRy BseUxqeGlj ajQxIExpQk 1ZWFZ1WTIg Z2diMllnWm 1seSBjM1Fn WkhKMVp5IE JtYjNJZ2FI bHcgWlhKMF pXNXphVyA5 dU9pQkpiaU F4IE9UWTNM Q0JQYm0gOG dVR2hoY20x aCBZMlYxZE dsallXIHdn YkdGMWJtTm 8gWldRZ2RH aGxJRyBacG NuTjBJR0Z1 IGRHbG9lWE JsY24gUmxi bk5wZG1VZy BaSEoxWnlC cGJpIEJLWV hCaGJpQmog WVd4c1pXUW dRMiBGd2Iz UmxiaTQ4IF luSStOaTRn U1cgNTBjbT lrZFdOMCBh Vzl1SUc5bU lIIFJvWlNC bWFYSnogZE NCS1lYQmhi bSBWelpTMX RZV1JsIElH RnVkR2xqWV cgNWpaWEln WkhKMSBaem 9nU1c0Z01U IGszTkN3Z2 RHaGwgSUdO dmJYQmhibi BrZ2FXNTBj bTlrIGRXTm xaQ0IwYUcg VWdabWx5Yz NRZyBTbUZ3 WVc1bGMyIF V0YldGa1pT QmggYm5ScF kyRnVZMiBW eUlHUnlkV2 NnIFkyRnNi R1ZrSUUgSn ZjMk5vSUZC byBZWEp0WV N3Z2QyIGhw WTJnZ2FYTW cgYzNScGJH d2dkMiBsa1 pXeDVJSFZ6 IFpXUWdkRz lrWVgga3VQ R0p5UGpjdS BJRU52Ykd4 aFltIDl5WV hScGIyNGcg ZDJsMGFDQk 1hVyB4c2VU b2dTVzRnIE 1UazRNaXdn VDIgNXZJRk JvWVhKdCBZ V05sZFhScF kyIEZzSUdW dWRHVnkgWl dRZ2FXNTBi eSBCaElHTn ZiR3hoIFlt OXlZWFJwYj IgNGdkMmww YUNCRiBiR2 tnVEdsc2JI IGtnWVc1a0 lFTnYgYlhC aGJua2dkRy A4Z1pHVjJa V3h2IGNDQm hibVFnYlcg RnlhMlYwSU hCbyBZWEp0 WVdObGRYIF JwWTJGc0lI QnkgYjJSMV kzUnpJRyBs dUlFcGhjR0 Z1IExqeGlj ajQ0TGkgQl FZWEowYm1W eSBjMmhwY0 NCM2FYIFJv SUVKeWFYTj AgYjJ3dFRY bGxjbiBNZ1 UzRjFhV0pp IE9pQkpiaU F5TUQgQTJM Q0JQYm04Zy BVR2hoY20x aFkyIFYxZE dsallXd2cg YzJsbmJtVm tJRyBGdUlH Rm5jbVZsIG JXVnVkQ0Iz YVggUm9JRU p5YVhOMCBi Mnd0VFhsbG NuIE1nVTNG MWFXSmkgSU dadmNpQjBh RyBVZ1kyOH RaR1YyIFpX eHZjRzFsYm 4gUWdZVzVr SUdOdiBMV0 52YlcxbGNt IE5wWVd4cG VtRjAgYVc5 dUlHOW1JRy BSeWRXZHpJ R1p2IGNpQm pZVzVqWlgg SXNJR05sYm 5SeSBZV3dn Ym1WeWRtID kxY3lCemVY TjAgWlcwZ1 pHbHpiMyBK a1pYSnpMQ0 JoIGJtUWdZ WFYwYjIgbH RiWFZ1WlNC ayBhWE5sWV hObGN5IDQ4 WW5JK09TNG cgUjJ4dllt RnNJRyBWNG NHRnVjMmx2 IGJqb2dUMj V2SUYgQm9Z WEp0WVdObC BkWFJwWTJG c0lHIGhoY3 lCbGVIQmgg Ym1SbFpDQn BkSCBNZ1lu VnphVzVsIG MzTWdkRzhn YjMgWmxjaU E0TkNCaiBi M1Z1ZEhKcF pYIE1nWVc1 a0lISmwgWj JsdmJuTWdZ WCBKdmRXNW tJSFJvIFpT QjNiM0pzWk Mgd2dkMmww YUNCaCBJR1 p2WTNWeklH IDl1SUVGem FXRXMgSUU1 dmNuUm9JRS BGdFpYSnBZ MkVzIElHRn VaQ0JGZFgg SnZjR1V1UE dKeSBQakV3 TGlCVGRYIE 4wWVdsdVlX SnMgWlNCa1 pYWmxiRyA5 d2JXVnVkRG 9nIFZHaGxJ R052YlggQm hibmtnYVhN ZyBZMjl0Yl dsMGRHIFZr SUhSdklITj EgYzNSaGFX NWhZbSB4bE lHUmxkbVZz IGIzQnRaVz UwSUcgRnVa Q0JvWVhNZy BjMlYwSUdk dllXIHh6SU hSdklISmwg WkhWalpTQn BkSCBNZ1pX NTJhWEp2IG JtMWxiblJo YkMgQnBiWE JoWTNRcyBJ SEJ5YjIxdm RHIFVnWkds MlpYSnogYV hSNUlHRnVa QyBCcGJtTn NkWE5wIGIy NHNJR0Z1Wk MgQmpiMjUw Y21saSBkWF JsSUhSdklI IE52WTJsbG RIa2cgZEdo eWIzVm5hQy BCMllYSnBi M1Z6IElHbH VhWFJwWVgg UnBkbVZ6TG c9PQogICAg ICAgIDwvc3 Bhbj4KICAg ICAgICAKIC AgICAgICA=